glp 1 hims & @Hers sees strong early results from its GLP-1 weight loss program. New internal data shows users lost an average of 20.9 pounds in six months, with high adherence and low Hims to begin selling GLP-1

Cost Concerns The high cost of GLP-1 drugs, especially for weight loss purposes, is another driving factor behind the microdosing trend

Overview of Depression Major depressive disorder (MDD) is a highly prevalent mood disorder characterized by ruminative thoughts, impaired cognition and anhedonia, and attentional control deficits (Marchetti et al., 2012

In an extension of the STEP-1 trial, participants originally randomized to semaglutide regained 68% of their lost weight after one year of discontinuing treatment

Exploring cutting-edge approaches in diabetes care: from nanotechnology to personalized therapeutics

Singh added that results from the ongoing FOCUS studya long-term ophthalmic endpoint trial evaluating semaglutide versus placebo in patients with type 2 diabeteswill be critical in clarifying the long-term retinal safety profile of GLP-1 therapies

Our Hormone Transitions and Longevity Medicine page provides additional context